Published in Drug Dev Res on November 15, 2013
Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (1962) 18.89
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA (2011) 6.39
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med (2008) 2.51
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost (2009) 1.72
The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods (1980) 1.66
Systemic blood coagulation activation in acute coronary syndromes. Blood (2008) 1.53
Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts. Blood (2013) 1.48
Relationship between thrombin generation and carotid intima-media thickness. Hamostaseologie (2010) 1.40
Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol (2011) 1.38
Role of platelets in atherothrombosis. Am J Cardiol (2009) 1.36
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation (1994) 1.28
Genotyping and phenotyping of platelet function disorders. J Thromb Haemost (2013) 1.19
Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost (2011) 1.12
Increased soluble form of P-selectin in patients with unstable angina. Circulation (1995) 1.11
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost (2011) 1.08
Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets (2007) 1.06
Deciphering the human platelet sheddome. Blood (2010) 1.04
A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol (1995) 0.98
Clinical application of the PFA-100. Curr Opin Hematol (2002) 0.98
The laboratory and the direct oral anticoagulants. Blood (2013) 0.97
Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost (2013) 0.92
The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets (2008) 0.90
Laboratory evaluation of hypercoagulability. Clin Lab Med (2009) 0.89
Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci (1998) 0.89
Thrombin generation in patients with a first acute myocardial infarction. J Thromb Haemost (2011) 0.89
Medical management after coronary stent implantation: a review. JAMA (2013) 0.89
Thrombin generation in clinical conditions. Thromb Res (2011) 0.88
Expression of ligand-induced binding sites on glycoprotein IIb/IIIa complexes and the effect of various inhibitors. Am Heart J (1998) 0.87
The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost (2009) 0.87
Laboratory testing of anticoagulants: the present and the future. Pathology (2011) 0.86
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test. Thromb Haemost (2008) 0.86
Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. Thromb Res (2009) 0.84
Diagnostic approach to platelet function disorders. Transfus Apher Sci (2008) 0.84
D-dimer testing in laboratory practice. Clin Chem (2011) 0.83
Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood (1989) 0.82
Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura. Am J Clin Pathol (1991) 0.82
Thrombotic disorders: diagnosis and treatment. Hematology Am Soc Hematol Educ Program (2003) 0.82
Heterogeneous defects of platelet secretion and responses to weak agonists in patients with bleeding disorders. Br J Haematol (1988) 0.82
Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. Curr Opin Cardiol (2008) 0.80
Platelet function testing and prediction of procedural bleeding risk. Thromb Haemost (2013) 0.80
Testing platelet function. Hematol Oncol Clin North Am (2013) 0.80
Assessment of lumiaggregometry for research and clinical laboratories. Thromb Haemost (1992) 0.79
Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment. Int J Cardiol (2013) 0.79
The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIB-IIIa antagonists. J Thromb Thrombolysis (2004) 0.79
Evaluation of the Platelet Mapping Assay on rotational thromboelastometry ROTEM. Platelets (2009) 0.78
Modern antiplatelet management of coronary artery bypass patients: a role of platelet function testing in decision making. J Thromb Thrombolysis (2014) 0.76
Duration of anticoagulation: applying the guidelines and beyond. Hematology Am Soc Hematol Educ Program (2010) 0.76
Platelet function tests for the monitoring of P2Y12 inhibitors. Expert Opin Med Diagn (2010) 0.76
Macrothrombocytopenia in velocardiofacial syndrome. J Thromb Haemost (2005) 0.76